Larimar Therapeutics Inc (LRMR)
SG&A Expenses
$21.75M
TTM · Period ending: · USD
LRMR SG&A Expenses
Latest reported$21.75Mperiod ending
Latest reported$21.75Mperiod ending
LRMR TTM SG&A Expenses ($19.20M → $21.75M)
TTM SG&A Expenses
High-resolution chart · PNG
LRMR sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 21,750,000 | |
| 19,823,000 | |
| 18,373,000 | |
| 18,283,000 | |
| 17,960,000 | |
| 18,453,000 | |
| 17,612,000 | |
| 16,571,000 | |
| 15,980,000 | |
| 14,808,000 | |
| 14,088,000 | |
| 13,795,000 | |
| 12,972,000 | |
| 12,270,000 | |
| 12,276,000 | |
| 11,849,000 | |
| 11,620,000 | |
| 12,018,000 | |
| 12,069,000 | |
| 13,097,000 | |
| 13,811,000 | |
| 12,862,000 | |
| 11,397,000 | |
| 8,327,000 | |
| 5,505,000 | |
| 3,589,000 | |
| 1,922,502 | |
| 4,404,502 | |
| 7,149,502 | |
| 9,924,502 | |
| 13,193,000 | |
| 12,406,000 | |
| 12,184,000 | |
| 11,841,000 | |
| 12,160,000 | |
| 12,913,000 | |
| 14,626,000 | |
| 16,517,000 | |
| 18,289,000 | |
| 20,629,000 | |
| 21,345,000 | |
| 21,530,000 | |
| 19,195,000 | |
| 15,940,000 | |
| 11,685,000 |